In ALS, cytosolic TDP-43 elicits innate immune responses through mitochondrial damage and activation of the cGAS/STING pathway (Ma et al., 2024
TB-500 is a fragment of Thymosin Beta-4, working primarily through actin regulation and cell migration, with strong support for skin wound healing and cardiac tissue
Thats why we tailor every GLP-1 program to the individualtaking into account your hormone health, lifestyle, and specific symptoms
Dear Marci, My doctor and I have been discussing some of the new GLP-1 weight loss medications
It's a fundamental expansion of the therapeutic strategy being investigated
Resmetirom (Rezdiffra TM ), a liver-directed thyroid hormone receptor- (THR-) agonist, received accelerated FDA approval in March 2024 as the first agent specifically indicated for non-cirrhotic MASH with moderate-to-advanced fibrosis (F2-F3), based on the MAESTRO-NASH trial demonstrating MASH resolution and fibrosis improvement